Clinical Trial Update: Add-on Mirabegron in Pediatric Patients With Refractory Overactive Bladder [Phase 3]

View source ↗

Summary

Phase 3 trial assessing add-on mirabegron in pediatric patients with refractory overactive bladder completed. Results were posted on 2018-04-24.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urinary Incontinence

Drugs mentioned

• Mirabegron (mirabegron)

Snippet

Sponsor: CHU de Quebec-Universite Laval | Conditions: Overactive Bladder, Urinary Incontinence | Phase 3 | Status: COMPLETED | Results posted: 2018-04-24